00000nam 2200000za 4500 9.825318 CaOODSP 20221107144328 cr ||||||||||| 161003s2016 onc ob f000 0 eng d CaOODSP eng n-cn--- H113-9/2016-26E-PDF Bacillus mycoides isolate J [electronic resource]. Ottawa : Health Canada, c2016. 44 p. Proposed registration decision, 1925-0886 ; PRD2016-26 Issued also in French under title: Isolat J de Bacillus mycoides. "28 September 2016.” Includes references. "Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of BmJ TGAI and BmJ WG, containing the technical grade active ingredient Bacillus mycoides isolate J, for the suppression or partial suppression of certain fungal diseases on food crops. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of BmJ TGAI and BmJ WG"--Overview. Issued also in printed form. gccst Pesticides gccst Certification gccst Toxicology Canada. Health Canada. Canada. Pest Management Regulatory Agency. Isolat J de Bacillus mycoides (CaOODSP)9.825321 Proposed registration decision, 1925-0886 ; PRD2016-26 (CaOODSP)9.504464 PDF 361 KB https://publications.gc.ca/collections/collection_2016/sc-hc/H113-9-2016-26-eng.pdf